Structured evidence table for Beta Glucan Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Beta Glucan Gut Health Randomized Trial | By interacting with innate pattern recognition receptors (PRRs), including Dectin-1 and Toll-like receptors (TLRs), expressed on gut-associated lymphoid tissue (GALT) and immune cells, β-1,3-glucans regulate both innate and adaptive immune responses [,]. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Gut Health Randomized Trial | Table 2 A summary of β-glucans derived from different fungal sources and their associated therapeutic properties is provided in. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Gut Health Randomized Trial | Although multiple receptor systems are involved, the overall framework is conserved and relies on the detection of pathogen-associated molecular patterns (PAMPs) by PRR families, including Dectin-1, TLRs, complement receptor 3 (CR3), lactosylceramide (LacCer), and scavenger receptors (SRs). | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Gut Health Randomized Trial | 1 2 2 Glucans are polysaccharides composed entirely of glucose monomers and are generally classified into three structural categories: α-glucans, β-glucans, and mixed α, β-glucans [,]. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Gut Health Randomized Trial | Functional prediction analysis specifically linked this microbial shift to the modulation of Akkermansia -associated metabolic pathways, which subsequently facilitated the activation of host metabolic networks to combat lipid deposition and systemic metabolic stress. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
| Beta Glucan Gut Health Randomized Trial | Background/objectives Although plant-derived dietary fiber and protein are favorable factors for improving host metabolic disorders, it remains unclear whether these two macronutrients exhibit synergistic health benefits. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
| Beta Glucan Gut Health Randomized Trial | Methods To address this gap, utilizing oat dietary fiber (GLU) and soybean protein (SBP) as representative bioactive models, we investigated the effects of 5% GLU, 20% SBP, and their combined supplementation on high-fat diet (HFD)-induced metabolic dysregulation in C57BL/6J mice. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
Source documents